Psyence Biomedical (PBM) Current Assets (2023 - 2025)
Psyence Biomedical (PBM) recorded quarterly Current Assets of $7.6 million in Q3 2025, up 16.3% quarter-over-quarter from $6.6 million in Q1 2025, and up 240.09% on a YoY basis from $2.2 million in Q3 2024.
Psyence Biomedical (PBM) Current Assets (2023 - 2025) Analysis & Trends
Psyence Biomedical's Current Assets history runs 3 years deep, the most recent figure standing at $7.6 million for Q3 2025.
- In Q3 2025, Current Assets rose 240.09% year-over-year to $7.6 million; the TTM figure through Sep 2025 stood at $7.6 million (up 240.09% YoY), while the FY2025 annual figure was $6.6 million, up 482.27% from the prior year.
- Current Assets was $7.6 million for Q3 2025 at Psyence Biomedical, up from $6.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $7.6 million in Q3 2025 to a low of $1.1 million in Q1 2024.
- Historically, Current Assets has averaged $3.8 million across 3 years, with a median of $2.2 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Current Assets slipped 29.15% in 2024, then jumped 482.27% in 2025.
- A 3-year view of Current Assets shows it stood at $1.6 million in 2023, then jumped by 41.07% to $2.2 million in 2024, then surged by 240.09% to $7.6 million in 2025.
- The last three Current Assets figures came in at $7.6 million (Q3 2025), $6.6 million (Q1 2025), and $2.2 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 600.85 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 18.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.63 Mn |
| Mar 31, 2025 | 6.56 Mn |
| Sep 30, 2024 | 2.24 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Mar 31, 2023 | 1.59 Mn |